Health Trials

Clinical trials

4

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Multicentre, Randomised, Double-blind, Positive-control Clinical Trial Evaluating Dihydroartemisinin Tablets for the Treatment of Discoid Lupus Erythematosus

This study is a multicentre, randomised, double-blind, double-dummy, phase II clinical trial with a positive-control group, designed to evaluate the efficacy and safety of dihydroartemisinin tablets in the treatment of discoid lupus erythematosus (DLE).

Participants needed: 100
Trial details
Phase: Phase 2Age: 18-65Biological sex: AllType: InterventionalSponsor: Kunming Pharmaceuticals, Inc.Updated: Apr 30, 2026Locations: 10
Eligibility criteria

Participants are able to understand the purpose and risks of the study and volun... [+4]

Patients with systemic lupus erythematosus (SLE) or those at high risk of develo... [+22]

Read more
Status: Not yet recruiting

A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetic Profile of Gastrodin Injection in Healthy Chinese Subjects

This is a single-center, double-blind study to evaluate the safety, tolerability, pharmacokinetics of Gastrodin Injection in healthy Subjects

Participants needed: 54
Trial details
Phase: Phase 1Age: 18-65Biological sex: AllType: InterventionalSponsor: Kunming Pharmaceuticals, Inc.Updated: Feb 19, 2026Locations: 1
Eligibility criteria

Subjects must have a full understanding of the trial's purpose, nature, procedur... [+3]

Subjects who developed acute diseases within 2 weeks prior to screening, such as... [+18]

Read more
Status: Recruiting

Efficacy and Safety of the KPCXM18 Injection in Patients With Acute Ischemic Stroke

This study is a multicenter, randomized, double-blind, parallel, placebo-controlled trial design to evaluate the efficacy and safety of the KPCXM18 injection at different doses for the treatment of acute ischemic stroke.

Participants needed: 300
Trial details
Phase: Phase 2Age: 18-80Biological sex: AllType: InterventionalSponsor: Kunming Pharmaceuticals, Inc.Updated: Dec 12, 2025Locations: 23
Eligibility criteria

1. Age 18 to 80 years old (including 18 years old and 80 years old, based on the... [+6]

1. Patients with intracranial hemorrhagic diseases confirmed by Imaging: hemorrh... [+17]

Read more
Status: Not yet recruiting

A Trial to Evaluate KPC000154 Tablets in Healthy Subjects

A Phase I Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of KPC000154 Tablets in Healthy Subjects

Participants needed: 92
Trial details
Phase: Phase 1Age: 18-55Biological sex: AllType: InterventionalSponsor: Kunming Pharmaceuticals, Inc.Updated: Mar 10, 2025Locations: 1
Eligibility criteria

Subjects must fully understand the purpose, nature, procedures of the trial, and... [+4]

Individuals with an allergic constitution (e.g., known allergies to two or more... [+26]

Read more